InsiderTrades.com logo
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

GENF Insider Trading

Insider Ownership Percentage: 63.66%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Genflow Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Genflow Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Genflow Biosciences Share Price & Price History

Current Price: GBX 1.60
Price Change: ▲ Price Increase of +0.05 (3.23%)
As of 04/24/2024 05:29 PM ET

This chart shows the closing price history over time for GENF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Genflow Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Eric LeireInsiderBuy308,999GBX 3£9,269.97
See Full Table
Global crypto currency reset (41 major banks signed up)
From Stansberry Research   |   Ad
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
 Here's everything you need to know.

SEC Filings (Institutional Ownership Changes) for Genflow Biosciences (LON:GENF)

9.15% of Genflow Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Read More on Genflow Biosciences

Today's Range

Now: GBX 1.60
Low: 1.57
High: 1.60

50 Day Range

MA: GBX 1.51
Low: 1.35
High: 1.72

52 Week Range

Now: GBX 1.60
Low: 1.32
High: 4.70

Volume

46,843 shs

Average Volume

1,180,893 shs

Market Capitalization

£5.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.47

Who are the company insiders with the largest holdings of Genflow Biosciences?

Genflow Biosciences' top insider investors include:
  1. Eric Leire (Insider)
Learn More about top insider investors at Genflow Biosciences.
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry